XSHE
002817
Market cap304mUSD
Oct 09, Last price
6.83CNY
1D
0.15%
1Q
11.78%
Jan 2017
-58.63%
IPO
7.19%
Name
Anhui Huangshan Capsule Co Ltd
Chart & performance
P/E
31.44
P/S
4.46
EPS
0.22
Div yield, %
1.44%
Shrs. gr., 5y
—
Rev. gr., 5y
1.34%
Revenues
458m
-3.30%
Net income
65m
+31.94%
CFO
107m
+69.17%
Dividend
May 26, 20260.053 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Anhui Huangshan Capsule Co., Ltd. is engaged in the research, development, manufacture and sale of gelatin hollow capsules. Its products include entersoluble vacant gelatin, vegetable entersoluble, vacant gelatin, vegetable, and pulluan capsule. The company was founded in 1989 and is headquartered in Xuancheng, China.
Key people
Qingke Liu
Chief Financial Officer · since 2022
Songlin Ye
General Manager · since 2025
Jian Fan
Deputy General Manager · since 2025
Wenzheng Zhang
Deputy General Manager, Secretary of the Board · since 2023
Zhenhua Chu
Deputy General Manager, Director · since 2025
Hejun Li
Chairman of the Board · since 2022
Yaping Wang
Director · since 2022
Baozhen Wang
Staff Elected Director · since 2025
Zhongxun Wei
Director · since 2022
Chaobiao Yu
Director · since 2025
Independent Director · since 2025
Qinghua Wang
Independent Director · since 2022
Xibu Zhao
Independent Director · since 2022
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2024‑00 | 2023‑12 | 2023‑00 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||